Volkan Aslan

ORCID: 0000-0001-5685-3748
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer Immunotherapy and Biomarkers
  • Inflammatory Biomarkers in Disease Prognosis
  • Pancreatic and Hepatic Oncology Research
  • Cancer Genomics and Diagnostics
  • Renal cell carcinoma treatment
  • Immunotherapy and Immune Responses
  • Endometrial and Cervical Cancer Treatments
  • Immune Cell Function and Interaction
  • Biomarkers in Disease Mechanisms
  • Sarcoma Diagnosis and Treatment
  • Renal and related cancers
  • Neurofibromatosis and Schwannoma Cases
  • Pharmaceutical studies and practices
  • Lung Cancer Treatments and Mutations
  • Biosimilars and Bioanalytical Methods
  • Colorectal and Anal Carcinomas
  • Immune cells in cancer
  • Nutrition and Health in Aging
  • Statistical Methods in Clinical Trials
  • Cervical Cancer and HPV Research
  • Gastrointestinal Tumor Research and Treatment

Gazi University
2021-2024

Gazi Hastanesi
2021

Resistance to immune checkpoint inhibitors (ICI) is a significant issue in metastatic renal cell carcinoma (mRCC), as it the majority of cancer types. An important deficiency immunooncology today lack predictive factor identify this patient group. Myeloid-derived suppressor cells (MDSC) are type that contributes immunotherapy resistance by inhibiting T activity. While accumulates tumor microenvironment and blood, can also accumulate lymphoid organs such spleen cause splenomegaly. Therefore...

10.1186/s12885-023-11558-y article EN cc-by BMC Cancer 2023-10-30

The relationship of the ABO blood group system with immune response is known, but its checkpoint inhibitors (ICIs) has not been clearly investigated until now.In this study, between different groups and nivolumab treatment in patients advanced malignant melanoma was investigated.The data who used for April 2018 2021 were retrospectively reviewed.A total 73 included study. In progression-free survival (PFS) analysis according to groups, it 3.9 months, 16.1 20.0 months 3.0 A, B, AB O,...

10.3233/cbm-210455 article EN Cancer Biomarkers 2022-01-04

ABS TRACT Objective:The vast majority of pancreatic carcinoma patients have unresectable or metastatic disease at the time diagnosis.Therefore, 5-year survival rate is approximately 10%.FOLFIRINOX used as a standard first-line therapy in with good performance status and single agent for poor performance.Our study aimed to compare combination FOLFIRINOX gemcitabine plus platinum-based treatment cancer.Material Methods: Patients diagnosed locally cancer Gazi University Hospital between 01.2012...

10.37047/jos.2023-100383 article EN cc-by-nc-nd Journal of Oncological Sciences 2024-01-01

Introduction To evaluate biosimilar understanding and preference trends of medical oncologists in Turkey. Methods A survey consisting 24 multiple-choice questions with checkbox answers was conducted among oncologists. The questionnaire divided into five parts to some intentions: demographic characteristics, general knowledge about biosimilars, local approval reimbursement issues, individual trends, ranking the their own. All were analyzed as whole cohort, specialists fellows. Results Fellows...

10.1177/10781552211031643 article EN Journal of Oncology Pharmacy Practice 2021-07-27

Abstract Introduction: Gastrointestinal Stromal Tumors mostly located in the stomach and esophageal GIST is extremely rare. Various genetic disorders increase risk of developing GIST, among these, NF-1 most common. A case posterior mediastial neurofibromatosis patient has not been reported yet. Case: 48-year-old male being evaluated with complaints dyspnea progressive dysphagia. Computed tomography detected a cystic, lobulated contour mass that was at mediastinum measuring 11 x 14x12 cm. The...

10.21203/rs.3.rs-748331/v1 preprint EN cc-by Research Square (Research Square) 2021-08-03
Coming Soon ...